A novel heterozygous intronic mutation in POU1F1 is associated with combined pituitary hormone deficiency

Masaki Takagi, Hotaka Kamasaki, Hiroko Yagi, Ryuji Fukuzawa, Satoshi Narumi, Tomonobu Hasegawa

Research output: Contribution to journalComment/debate

3 Citations (Scopus)

Abstract

POU class 1 homeobox 1 (POU1F1) regulates pituitary cell-specific gene expression of somatotropes, lactotropes, and thyrotropes. In humans, two POU1F1 isoforms (long and short isoform), which are generated by the alternative use of the splice acceptor site for exon 2, have been identified. To date, more than 30 POU1F1 mutations in patients with combined pituitary hormone deficiency (CPHD) have been described. All POU1F1 variants reported to date affect both the short and long isoforms of the POU1F1 protein; therefore, it is unclear at present whether a decrease in the function of only one of these two isoforms is sufficient for disease onset in humans. Here, we described a sibling case of CPHD carrying a heterozygous mutation in intron 1 of POU1F1. In vitro experiments showed that this mutation resulted in exon 2-skipping of only in the short isoform of POU1F1, while the long isoform remained intact. This result strongly suggests the possibility, for the first time, that isolated mutations in the short isoform of POU1F1 could be sufficient for induction of POU1F1-related CPHD. This finding improves our understanding of the molecular mechanisms, and developmental course associated with mutations in POU1F1.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalEndocrine Journal
Volume64
Issue number2
DOIs
Publication statusPublished - 2017

Fingerprint

Protein Isoforms
Mutation
Exons
RNA Splice Sites
Homeobox Genes
Combined Pituitary Hormone Deficiency
Introns
Siblings
Gene Expression

Keywords

  • Combined pituitary hormone deficiency
  • Exon trapping
  • Pou1f1
  • Short isoform

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A novel heterozygous intronic mutation in POU1F1 is associated with combined pituitary hormone deficiency. / Takagi, Masaki; Kamasaki, Hotaka; Yagi, Hiroko; Fukuzawa, Ryuji; Narumi, Satoshi; Hasegawa, Tomonobu.

In: Endocrine Journal, Vol. 64, No. 2, 2017, p. 229-234.

Research output: Contribution to journalComment/debate

Takagi, Masaki ; Kamasaki, Hotaka ; Yagi, Hiroko ; Fukuzawa, Ryuji ; Narumi, Satoshi ; Hasegawa, Tomonobu. / A novel heterozygous intronic mutation in POU1F1 is associated with combined pituitary hormone deficiency. In: Endocrine Journal. 2017 ; Vol. 64, No. 2. pp. 229-234.
@article{c1d8e15cf0e147c0bc0851394e514018,
title = "A novel heterozygous intronic mutation in POU1F1 is associated with combined pituitary hormone deficiency",
abstract = "POU class 1 homeobox 1 (POU1F1) regulates pituitary cell-specific gene expression of somatotropes, lactotropes, and thyrotropes. In humans, two POU1F1 isoforms (long and short isoform), which are generated by the alternative use of the splice acceptor site for exon 2, have been identified. To date, more than 30 POU1F1 mutations in patients with combined pituitary hormone deficiency (CPHD) have been described. All POU1F1 variants reported to date affect both the short and long isoforms of the POU1F1 protein; therefore, it is unclear at present whether a decrease in the function of only one of these two isoforms is sufficient for disease onset in humans. Here, we described a sibling case of CPHD carrying a heterozygous mutation in intron 1 of POU1F1. In vitro experiments showed that this mutation resulted in exon 2-skipping of only in the short isoform of POU1F1, while the long isoform remained intact. This result strongly suggests the possibility, for the first time, that isolated mutations in the short isoform of POU1F1 could be sufficient for induction of POU1F1-related CPHD. This finding improves our understanding of the molecular mechanisms, and developmental course associated with mutations in POU1F1.",
keywords = "Combined pituitary hormone deficiency, Exon trapping, Pou1f1, Short isoform",
author = "Masaki Takagi and Hotaka Kamasaki and Hiroko Yagi and Ryuji Fukuzawa and Satoshi Narumi and Tomonobu Hasegawa",
year = "2017",
doi = "10.1507/endocrj.EJ16-0361",
language = "English",
volume = "64",
pages = "229--234",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "2",

}

TY - JOUR

T1 - A novel heterozygous intronic mutation in POU1F1 is associated with combined pituitary hormone deficiency

AU - Takagi, Masaki

AU - Kamasaki, Hotaka

AU - Yagi, Hiroko

AU - Fukuzawa, Ryuji

AU - Narumi, Satoshi

AU - Hasegawa, Tomonobu

PY - 2017

Y1 - 2017

N2 - POU class 1 homeobox 1 (POU1F1) regulates pituitary cell-specific gene expression of somatotropes, lactotropes, and thyrotropes. In humans, two POU1F1 isoforms (long and short isoform), which are generated by the alternative use of the splice acceptor site for exon 2, have been identified. To date, more than 30 POU1F1 mutations in patients with combined pituitary hormone deficiency (CPHD) have been described. All POU1F1 variants reported to date affect both the short and long isoforms of the POU1F1 protein; therefore, it is unclear at present whether a decrease in the function of only one of these two isoforms is sufficient for disease onset in humans. Here, we described a sibling case of CPHD carrying a heterozygous mutation in intron 1 of POU1F1. In vitro experiments showed that this mutation resulted in exon 2-skipping of only in the short isoform of POU1F1, while the long isoform remained intact. This result strongly suggests the possibility, for the first time, that isolated mutations in the short isoform of POU1F1 could be sufficient for induction of POU1F1-related CPHD. This finding improves our understanding of the molecular mechanisms, and developmental course associated with mutations in POU1F1.

AB - POU class 1 homeobox 1 (POU1F1) regulates pituitary cell-specific gene expression of somatotropes, lactotropes, and thyrotropes. In humans, two POU1F1 isoforms (long and short isoform), which are generated by the alternative use of the splice acceptor site for exon 2, have been identified. To date, more than 30 POU1F1 mutations in patients with combined pituitary hormone deficiency (CPHD) have been described. All POU1F1 variants reported to date affect both the short and long isoforms of the POU1F1 protein; therefore, it is unclear at present whether a decrease in the function of only one of these two isoforms is sufficient for disease onset in humans. Here, we described a sibling case of CPHD carrying a heterozygous mutation in intron 1 of POU1F1. In vitro experiments showed that this mutation resulted in exon 2-skipping of only in the short isoform of POU1F1, while the long isoform remained intact. This result strongly suggests the possibility, for the first time, that isolated mutations in the short isoform of POU1F1 could be sufficient for induction of POU1F1-related CPHD. This finding improves our understanding of the molecular mechanisms, and developmental course associated with mutations in POU1F1.

KW - Combined pituitary hormone deficiency

KW - Exon trapping

KW - Pou1f1

KW - Short isoform

UR - http://www.scopus.com/inward/record.url?scp=85014057068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014057068&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ16-0361

DO - 10.1507/endocrj.EJ16-0361

M3 - Comment/debate

C2 - 27885216

AN - SCOPUS:85014057068

VL - 64

SP - 229

EP - 234

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 2

ER -